-
3D Surgery Breakthrough: Dr. Renquan Zhang Talks Innovative Treatment for Elderly Esophageal Cancer Patients
From September 26 to 28, 2024, the China Anti-Cancer Association (CACA) and the CACA Integrative Esophageal Cancer Committee hosted the 2024 CACA Integrative Esophageal Cancer Academic Conference in Hefei. This prestigious event gathered leading experts in the field of esophageal cancer from China and abroad. The topics ranged from cancer prevention, early diagnosis and treatment,…
-
Mao Leads the Way: A New Era in Esophageal Cancer Treatment Commenced at CACA Conference
From September 26 to 28, 2024, the “2024 China Anti-Cancer Association Integrated Esophageal Cancer Academic Conference” was held grandly in Hefei, hosted by the China Anti-Cancer Association (CACA) and the CACA Integrated Esophageal Cancer Committee, with five subcommittees on esophageal cancer joining forces with Anhui Medical University’s First Affiliated Hospital. Alongside, the “16th China Anti-Cancer…
-
Breaking News: ISDE 2024 Spotlights Groundbreaking Predictive Vital Sign Tech for Esophageal Cancer Surgery
From September 22nd to 24th, 2024, the 20th International Society for Diseases of the Esophagus (ISDE) conference was grandly held in Edinburgh, Scotland. A study by Dr. Andrew Seely from the University of Ottawa’s Faculty of Medicine on predictive vital sign monitoring during the perioperative period for esophageal cancer was selected for abstract presentation at…
-
Filipa Fonseca Challenges Traditional EGJ Cancer Classification with Innovative Approach at ISDE 2024
From September 22nd to 24th, 2024, the 20th International Society for Diseases of the Esophagus (ISDE) conference was grandly held in Edinburgh, Scotland. Dr. Filipa Fonseca from the Lisbon Oncology Research Center presented a study on the modified Siewert classification for adenocarcinoma of the esophagogastric junction (EGJ) at the Late-Breaking Oral Abstract session (Abstract No.:…
-
Neo-AEGIS Study Unveils: Peroperative Chemo Stands Tall in Esophageal Cancer Treatment, Signaling a Customized Future
Neo-AEGIS Study Unveils: Peroperative Chemo Stands Tall in Esophageal Cancer Treatment, Signaling a Customized Future Editor’s Note: From September 22nd to 24th, 2024, the 20th International Esophageal Cancer Conference (ISDE) took place in Edinburgh, Scotland. The Neo-AEGIS study, which compared the efficacy of perioperative chemotherapy with the CROSS regimen (preoperative chemotherapy combined with radiotherapy) in…
-
ISDE 2024 | Groundbreaking: Prehabilitation Transforms Borderline Resectable Esophageal Cancer Patients into Surgical Candidates
The 20th International Society for Diseases of the Esophagus (ISDE) conference took place in Edinburgh, Scotland, from September 22nd to 24th, 2024. At the conference, a study by Dr. Krishna Moorthy from the Royal College of Surgeons in the UK on whether prehabilitation can increase the surgical opportunities for esophageal cancer patients was selected for…
-
Integrative Medicine Shines at CACA: Dr. Liu Hong Outlines New Horizons in Esophageal Cancer Treatment
From September 26 to 28, 2024, the China Anti-Cancer Association (CACA) and the CACA Integrative Esophageal Cancer Committee hosted the 2024 CACA Integrative Esophageal Cancer Academic Conference in Hefei. The conference, under the theme “Winning in Integration for Cancer Prevention and Treatment,” gathered the latest research developments and clinical experiences from experts in esophageal cancer…
-
One Health: United Efforts to Combat Resistance丨The Second One Health Antimicrobial Resistance Control Conference Kicks Off in Hangzho
Opening Ceremony On this beautiful autumn day in Hangzhou, the Second One Health Antimicrobial Resistance Control Conference officially kicked off. The conference began with a warm welcome from the Executive…
Connecting Medical Expertise through Media